Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

COPIKTRA (duvelisib) Indicated for chronic lymphocytic leukaemia

COPIKTRA (duvelisib) is a dual inhibitor of phosphoinositide 3-kinase (PI3K), which supports the growth of malignant B-cells. Image courtesy of Roadnottaken.



  • COPIKTRA
  • COPIKTRA
  • COPIKTRA

Go Top